← Back to Search

Closed Loop System

Algorithm Testing for Type 1 Diabetes

N/A
Waitlist Available
Research Sponsored by Medtronic Diabetes
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 3.5 months
Awards & highlights

Summary

This trial is testing whether a new cancer treatment is feasible and effective.

Eligible Conditions
  • Type 1 Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 3.5 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 3.5 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Diabetic Ketoacidosis (DKA) Event - Cohort A
Number of Diabetic Ketoacidosis (DKA) Event - Cohort C
Number of Severe Hypoglycemic Event - Cohort A
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Algorithm TestingExperimental Treatment1 Intervention
The main purpose of this cohort is to test the Digital Twin insulin delivery algorithm and the Meal Prediction algorithm The study population will be enrolled as 2 separate cohorts to test each algorithms individually
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cloud-based Digital Twin and Meal Prediction algorithms
2020
N/A
~130

Find a Location

Who is running the clinical trial?

Medtronic DiabetesLead Sponsor
67 Previous Clinical Trials
9,875 Total Patients Enrolled
~25 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top